Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Jul 2026 for APOGEE THERAPEUTICS INC, €1.9M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Carl Dambkowski: trading record in brief
This profile gathers the share dealings of Carl Dambkowski across 2 companies, led by Apogee Therapeutics, Inc. and Oruka Therapeutics, Inc. Over a trading history stretching from 11 June 2026 to 1 July 2026, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 1 July 2026 came the latest disclosure, a transaction for €1.9M in Apogee Therapeutics, Inc. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Carl Dambkowski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
16,500 shares@ US$132.73CommonSEC144:0001950047-26-006771
1 of 1 declaration
